Anti-Neoplastic Pharmaceutical Agents Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: A61AC07EF643EN
Market Monitor Global

Abstracts

Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.

This report contains market size and forecasts of Anti-Neoplastic Pharmaceutical Agents in Global, including the following market information:

Global Anti-Neoplastic Pharmaceutical Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-Neoplastic Pharmaceutical Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hormones and Antagonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-Neoplastic Pharmaceutical Agents include GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Bristol-Myers Squibb Company, Becton, Dickinson and Company, Pfizer Inc., Novartis AG, AstraZeneca and Gilead. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Neoplastic Pharmaceutical Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Neoplastic Pharmaceutical Agents Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-Neoplastic Pharmaceutical Agents Market Segment Percentages, by Type, 2021 (%)

• Hormones and Antagonists
• Microorganism Products
• Plant Products
• Antitumor Antibiotics
• Alkylating Agents
• Antimetabolites
• Natural Products

Global Anti-Neoplastic Pharmaceutical Agents Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-Neoplastic Pharmaceutical Agents Market Segment Percentages, by Application, 2021 (%)

• Lung Cancer
• Bladder Cancer
• Breast Cancer
• Cervical Cancer
• Leukemia
• Gynecological Cancer
• Other

Global Anti-Neoplastic Pharmaceutical Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-Neoplastic Pharmaceutical Agents Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Neoplastic Pharmaceutical Agents revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-Neoplastic Pharmaceutical Agents revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline plc.
• F. Hoffmann-La Roche Ltd
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• Becton, Dickinson and Company
• Pfizer Inc.
• Novartis AG
• AstraZeneca
• Gilead

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-Neoplastic Pharmaceutical Agents Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-Neoplastic Pharmaceutical Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-NEOPLASTIC PHARMACEUTICAL AGENTS OVERALL MARKET SIZE

2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size: 2021 VS 2028
2.2 Global Anti-Neoplastic Pharmaceutical Agents Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-Neoplastic Pharmaceutical Agents Players in Global Market
3.2 Top Global Anti-Neoplastic Pharmaceutical Agents Companies Ranked by Revenue
3.3 Global Anti-Neoplastic Pharmaceutical Agents Revenue by Companies
3.4 Top 3 and Top 5 Anti-Neoplastic Pharmaceutical Agents Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-Neoplastic Pharmaceutical Agents Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Neoplastic Pharmaceutical Agents Players in Global Market
  3.6.1 List of Global Tier 1 Anti-Neoplastic Pharmaceutical Agents Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-Neoplastic Pharmaceutical Agents Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-Neoplastic Pharmaceutical Agents Market Size Markets, 2021 & 2028
  4.1.2 Hormones and Antagonists
  4.1.3 Microorganism Products
  4.1.4 Plant Products
  4.1.5 Antitumor Antibiotics
  4.1.6 Alkylating Agents
  4.1.7 Antimetabolites
  4.1.8 Natural Products
4.2 By Type - Global Anti-Neoplastic Pharmaceutical Agents Revenue & Forecasts
  4.2.1 By Type - Global Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2022
  4.2.2 By Type - Global Anti-Neoplastic Pharmaceutical Agents Revenue, 2023-2028
  4.2.3 By Type - Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-Neoplastic Pharmaceutical Agents Market Size, 2021 & 2028
  5.1.2 Lung Cancer
  5.1.3 Bladder Cancer
  5.1.4 Breast Cancer
  5.1.5 Cervical Cancer
  5.1.6 Leukemia
  5.1.7 Gynecological Cancer
  5.1.8 Other
5.2 By Application - Global Anti-Neoplastic Pharmaceutical Agents Revenue & Forecasts
  5.2.1 By Application - Global Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2022
  5.2.2 By Application - Global Anti-Neoplastic Pharmaceutical Agents Revenue, 2023-2028
  5.2.3 By Application - Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-Neoplastic Pharmaceutical Agents Market Size, 2021 & 2028
6.2 By Region - Global Anti-Neoplastic Pharmaceutical Agents Revenue & Forecasts
  6.2.1 By Region - Global Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2022
  6.2.2 By Region - Global Anti-Neoplastic Pharmaceutical Agents Revenue, 2023-2028
  6.2.3 By Region - Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2028
  6.3.2 US Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.3.3 Canada Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.3.4 Mexico Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2028
  6.4.2 Germany Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.4.3 France Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.4.4 U.K. Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.4.5 Italy Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.4.6 Russia Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.4.8 Benelux Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2028
  6.5.2 China Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.5.3 Japan Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.5.4 South Korea Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.5.6 India Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2028
  6.6.2 Brazil Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.6.3 Argentina Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2028
  6.7.2 Turkey Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.7.3 Israel Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028
  6.7.5 UAE Anti-Neoplastic Pharmaceutical Agents Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline plc.
  7.1.1 GlaxoSmithKline plc. Corporate Summary
  7.1.2 GlaxoSmithKline plc. Business Overview
  7.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.1.4 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline plc. Key News
7.2 F. Hoffmann-La Roche Ltd
  7.2.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.2.2 F. Hoffmann-La Roche Ltd Business Overview
  7.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Ltd Key News
7.3 Eli Lilly and Company
  7.3.1 Eli Lilly and Company Corporate Summary
  7.3.2 Eli Lilly and Company Business Overview
  7.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.3.4 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly and Company Key News
7.4 Bristol-Myers Squibb Company
  7.4.1 Bristol-Myers Squibb Company Corporate Summary
  7.4.2 Bristol-Myers Squibb Company Business Overview
  7.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.4.4 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Company Key News
7.5 Becton, Dickinson and Company
  7.5.1 Becton, Dickinson and Company Corporate Summary
  7.5.2 Becton, Dickinson and Company Business Overview
  7.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.5.4 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.5.5 Becton, Dickinson and Company Key News
7.6 Pfizer Inc.
  7.6.1 Pfizer Inc. Corporate Summary
  7.6.2 Pfizer Inc. Business Overview
  7.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.6.4 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Inc. Key News
7.7 Novartis AG
  7.7.1 Novartis AG Corporate Summary
  7.7.2 Novartis AG Business Overview
  7.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.7.4 Novartis AG Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.7.5 Novartis AG Key News
7.8 AstraZeneca
  7.8.1 AstraZeneca Corporate Summary
  7.8.2 AstraZeneca Business Overview
  7.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.8.4 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.8.5 AstraZeneca Key News
7.9 Gilead
  7.9.1 Gilead Corporate Summary
  7.9.2 Gilead Business Overview
  7.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Major Product Offerings
  7.9.4 Gilead Anti-Neoplastic Pharmaceutical Agents Revenue in Global Market (2017-2022)
  7.9.5 Gilead Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-Neoplastic Pharmaceutical Agents Market Opportunities & Trends in Global Market
Table 2. Anti-Neoplastic Pharmaceutical Agents Market Drivers in Global Market
Table 3. Anti-Neoplastic Pharmaceutical Agents Market Restraints in Global Market
Table 4. Key Players of Anti-Neoplastic Pharmaceutical Agents in Global Market
Table 5. Top Anti-Neoplastic Pharmaceutical Agents Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-Neoplastic Pharmaceutical Agents Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-Neoplastic Pharmaceutical Agents Product Type
Table 9. List of Global Tier 1 Anti-Neoplastic Pharmaceutical Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Neoplastic Pharmaceutical Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-Neoplastic Pharmaceutical Agents Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-Neoplastic Pharmaceutical Agents Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-Neoplastic Pharmaceutical Agents Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-Neoplastic Pharmaceutical Agents Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline plc. Corporate Summary
Table 31. GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 32. GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Ltd Corporate Summary
Table 34. F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 35. F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly and Company Corporate Summary
Table 37. Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 38. Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Company Corporate Summary
Table 40. Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 41. Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)
Table 42. Becton, Dickinson and Company Corporate Summary
Table 43. Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 44. Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Inc. Corporate Summary
Table 46. Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 47. Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)
Table 48. Novartis AG Corporate Summary
Table 49. Novartis AG Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 50. Novartis AG Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 53. AstraZeneca Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)
Table 54. Gilead Corporate Summary
Table 55. Gilead Anti-Neoplastic Pharmaceutical Agents Product Offerings
Table 56. Gilead Anti-Neoplastic Pharmaceutical Agents Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Neoplastic Pharmaceutical Agents Segment by Type in 2021
Figure 2. Anti-Neoplastic Pharmaceutical Agents Segment by Application in 2021
Figure 3. Global Anti-Neoplastic Pharmaceutical Agents Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-Neoplastic Pharmaceutical Agents Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Neoplastic Pharmaceutical Agents Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue in 2021
Figure 8. By Type - Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
Figure 12. US Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
Figure 16. Germany Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
Figure 24. China Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-Neoplastic Pharmaceutical Agents Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis AG Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Gilead Anti-Neoplastic Pharmaceutical Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)